SILINI, ENRICO MARIA
 Distribuzione geografica
Continente #
NA - Nord America 2.423
AS - Asia 1.914
EU - Europa 1.481
SA - Sud America 241
Continente sconosciuto - Info sul continente non disponibili 67
AF - Africa 54
OC - Oceania 4
AN - Antartide 1
Totale 6.185
Nazione #
US - Stati Uniti d'America 2.361
CN - Cina 1.020
SG - Singapore 371
IE - Irlanda 342
DE - Germania 211
UA - Ucraina 206
FI - Finlandia 183
HK - Hong Kong 181
BR - Brasile 179
VN - Vietnam 152
RU - Federazione Russa 146
FR - Francia 101
SE - Svezia 84
GB - Regno Unito 76
IT - Italia 70
CA - Canada 38
IN - India 37
JP - Giappone 32
BD - Bangladesh 24
IQ - Iraq 18
AR - Argentina 17
MX - Messico 16
ZA - Sudafrica 15
PL - Polonia 13
CO - Colombia 11
CZ - Repubblica Ceca 10
UZ - Uzbekistan 10
VE - Venezuela 10
ID - Indonesia 9
MA - Marocco 8
SA - Arabia Saudita 8
EC - Ecuador 7
CL - Cile 6
LT - Lituania 6
PK - Pakistan 6
TR - Turchia 6
BE - Belgio 5
NL - Olanda 5
PH - Filippine 5
PY - Paraguay 5
DZ - Algeria 4
ES - Italia 4
KE - Kenya 4
MY - Malesia 4
TN - Tunisia 4
AT - Austria 3
AZ - Azerbaigian 3
EG - Egitto 3
ET - Etiopia 3
EU - Europa 3
GA - Gabon 3
IL - Israele 3
KZ - Kazakistan 3
NP - Nepal 3
OM - Oman 3
PE - Perù 3
AO - Angola 2
AU - Australia 2
BO - Bolivia 2
CH - Svizzera 2
CR - Costa Rica 2
IR - Iran 2
LV - Lettonia 2
PS - Palestinian Territory 2
RO - Romania 2
SI - Slovenia 2
SN - Senegal 2
TH - Thailandia 2
AE - Emirati Arabi Uniti 1
AQ - Antartide 1
BG - Bulgaria 1
BH - Bahrain 1
BJ - Benin 1
BY - Bielorussia 1
CG - Congo 1
CI - Costa d'Avorio 1
CY - Cipro 1
EE - Estonia 1
GP - Guadalupe 1
GY - Guiana 1
HN - Honduras 1
HR - Croazia 1
JM - Giamaica 1
JO - Giordania 1
KG - Kirghizistan 1
KH - Cambogia 1
LB - Libano 1
LK - Sri Lanka 1
LY - Libia 1
ME - Montenegro 1
ML - Mali 1
MM - Myanmar 1
NG - Nigeria 1
NI - Nicaragua 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PG - Papua Nuova Guinea 1
PR - Porto Rico 1
PT - Portogallo 1
QA - Qatar 1
Totale 6.119
Città #
Dublin 342
Chandler 335
Jacksonville 296
Nanjing 239
Ashburn 222
San Jose 220
Beijing 181
Hong Kong 178
Singapore 172
Dallas 126
Boardman 99
Nanchang 88
Council Bluffs 74
Princeton 70
Hebei 68
Lawrence 63
Lauterbourg 61
Shenyang 60
Wilmington 59
Jiaxing 51
Los Angeles 51
Changsha 50
Munich 50
Tianjin 48
Hanoi 41
Hangzhou 40
Ho Chi Minh City 40
Medford 37
Moscow 34
Helsinki 33
Tokyo 31
Buffalo 26
New York 26
Milan 25
Orem 25
Ann Arbor 23
Shanghai 23
Redondo Beach 21
Turku 19
Santa Clara 17
Verona 17
Toronto 16
Norwalk 15
São Paulo 15
Frankfurt am Main 14
Brooklyn 13
Johannesburg 12
Warsaw 12
Woodbridge 12
Jinan 10
Montreal 10
Tashkent 10
Baghdad 9
Haiphong 9
Kunming 9
Brno 8
Chennai 8
Des Moines 8
Stockholm 8
Auburn Hills 7
Guangzhou 7
Mexico City 7
The Dalles 7
Biên Hòa 6
Boston 6
Dearborn 6
Dong Ket 6
Manchester 6
Phoenix 6
Seattle 6
Zhengzhou 6
Brussels 5
Chicago 5
Da Nang 5
London 5
San Francisco 5
Agadir 4
Atlanta 4
Bogotá 4
Buenos Aires 4
Charlotte 4
Curitiba 4
Falkenstein 4
Falls Church 4
Mumbai 4
Nairobi 4
Rio de Janeiro 4
Washington 4
Addis Ababa 3
Amsterdam 3
Asunción 3
Baku 3
Berlin 3
Bexley 3
Cardiff 3
Changchun 3
Columbus 3
Denver 3
Dhaka 3
Hòa Bình 3
Totale 4.064
Nome #
Multiple Papillomavirus Infection and Size of Colposcopic Lesions Among Women With Cervical Intraepithelial Neoplasia 146
Multiple human papillomavirus infection with or without type 16 and risk of cervical intraepithelial neoplasia among women with cervical cytological abnormalities. 141
Diagnostic accuracy of colposcopy in relation to human papillomavirus genotypes and multiple infection 131
Cross-reactive antibodies to hypervariable region 1 (HVR1) of the hepatitis C virus E2/gp70 glycoprotein 129
Untypable human papillomavirus infection and risk of cervical intraepithelial neoplasia among women with abnormal cervical cytology 129
Antibody responses to the hepatitis C virus (HCV) E2 protein: relationship to viraemia and prevalence in anti-HCV seronegative subjects. 120
CYP enzyme polymorphisms and susceptibility to HCV-related chronic liver disease and liver cancer. 120
Differential distribution of hepatitis C virus genotypes in patients with and without liver function abnormalities. 117
Coarse vs. fine needle aspiration biopsy for the assessment of diffuse liver disease from hepatitis C virus-related chronic hepatitis. 117
Codon 72 polymorphisms of P53 gene does not affect the risk of cirrhosis and hepatocarcinoma in HCV-infected patients 116
Cathepsin E in antigen-presenting Langerhans and interdigitating reticulum cells. Its possible role in antigen processing. 113
GB virus C infection in patients treated for childhood acute lymphoblastic leukemia 111
Su di uno "strano" epatocarcinoma 111
Evaluation of the HPV typing INNO-LiPA EXTRA assay on formalin-fixed paraffin-embedded cervical biopsy samples 111
Antibody-negative chronic hepatitis C virus infection in immunocompetent children 109
In vitro T-cell immune reactivity against promiscuous frames of hepatitis C virus core protein predicted by computational analysis 108
Comparative evaluation of two serologic typing methods of hepatitis C virus 105
Low prevalence of antibodies to the HCV envelope region in anti-HCV seronegative, HCV RNA positive patients 104
Analysis of hepatitis C virus hypervariable region 1 sequence in cryoglobulinaemic patients and associated control 104
HCV genotype 1b is a major risk factor for the development of hepatocellular carcinoma (HCC) in cirrhotic patients: a prospective study 103
Clinical significance of hepatitis C virus genotypes. 102
Association between class II allelles and protection or susceptibility to chronic hepatitis C 102
Comparative evaluation of two serological typing methods for hepatitis C virus 102
Modelling liver fibrosis progression in chronic hepatitis C: a study of 563 patients with sequential liver biopsies 100
Molecular epidemiology of hepatitis C virus infection in intravenous drug users. 100
Is the natural history of hepatitis C virus carriers with normal aminotransferase really bening? 99
Placental lesions associated with oligohydramnios in fetal growth restricted (FGR) pregnancies 98
HLA class II alleles confer protection or susceptibility to chronic hepatitis C 97
Epidemiology of HCV genotypes and risk of cirrhosis in apulia: a population-based case-control study 97
The impact of viral genotype on the natural history of HCV-induced cirrhosis: a prospective study 96
Hypervariable region 1 (HVR1) of HCV: immunological decoy or biologically relevant domain? 93
Hepatitis C virus (HCV) core serotypes in chronic HCV infection 93
HCV viremia in hemodialysis patients 92
Virological feaures of hepatitis C virus infection in hemodialysis patients 91
Antibody responses to hepatitis C virus hypervariable regione 1: evidence for cross-reactivity and immune-mediated sequence variation 91
Human leukocyte antigen class II and III alleles and severity of hepatitis C virus-related chronic liver disease. 91
HGV-GBV-C infection in liver transplant recipients. Antibodies to the viral E2 envelope glycoprotein protect from de novo infection 90
Different spectrum of liver disease in patients with HCV genotype II and III infection 90
Dynamic of hypervariable region 1 (HVR1) variation in hepatitis C virus infection and correlation with clinical and virological features of liver disease 89
Comparative evaluation of HCV core genotyping and serotyping 89
Polymporphisms of P450 genes and risk of hepatocellular carcinoma in HCV-infected patients. 88
HLA genes and chronic hepatitis C severity 87
Molecular epidemiology of hepatitis C virus infection in an area of hyperendemicity in Southern Italy: a population-based study. 86
HLA-DQA1, DQB1 heterodimers in chronic hepatitis C 86
Hepatitis C virus (HCV) infection in children treated for acute lymphoblastic leukemia (ALL) 85
Virological features of HCV infection in hemodialysis patients 84
Hepatitis C virus core serotypes in haemodialysis patients 83
HCV genotypes in the development of hepatocellular carcinoma (HCC) in anti-HCV positive cirrhotic patients: preliminary report of a prospective study 83
In vitro T-cell immune reactivity against promiscuous frames on hepatitis C virus core proteine predicted by computational analysis 81
Hepatitis C virus infection in children treated for acute lymhoblastic leukemia 80
Hepatitis C virus genotypes and risk of hepatocellular carcinoma in cirrhosis: a prospective study 79
Hepatitis C virus genotypes and risk of hepatocellular carcinoma in cirrhosis: a case-control study 75
Molecular epidemiology of hepatitis C virus infection among inravenous drug users 72
Genetic polymorphisms of steroid hormone metabolizing enzymes and risk of liver cancer in hepatitis C-infected patients. 70
High prevalence of hepatitis C virus genotype III infection in patient with normal liver enzymes and mild histologic lesions 70
Hepatitis C virus genotypes and risk of cirrhosis in Southern Italy 70
HLA class II and III and severity of hepatitis C virus (HCV)-related chronic liver disease 68
HVR1 variation, viral type and ALT values in chronic HCV infection 68
Vertical trasnmission of hepatitis C 67
Prevalenza di esposizione ad HGV in un day-hospital oncologico pediatrico 67
Molecular epidemiology of HCV infection in drug addicts 64
Genotipi del virus dell'epatite C e rischio di carcinoma epatocellulare: uno studio prospettico 64
Polymorphysms of glutathione s-trasnferase and epoxide hydrolase and severity of HCV-related liver disease 63
Significance of hepatitis C virus genotypes 62
Phylogenetic analysis of hepatitis G virus (HGV) 5'-non coding regione and development of a rapid PCR-based typing assay 54
Occurrence of antibodies reactive with more than one variant of the putative envelope glycoprotein (E2; gp70) hypervariable regione 1 in hepatitis C viremic patients 52
null 30
Totale 6.185
Categoria #
all - tutte 25.923
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 25.923


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022234 0 1 12 3 2 12 1 11 18 7 43 124
2022/2023982 125 77 6 69 108 99 0 55 403 8 25 7
2023/2024266 23 55 6 32 27 57 1 23 1 6 9 26
2024/2025797 30 76 40 28 2 18 34 43 197 17 127 185
2025/20261.968 168 212 188 209 241 89 350 53 209 137 60 52
2026/2027107 39 68 0 0 0 0 0 0 0 0 0 0
Totale 6.185